Delayed Function of Renal Transplant Clinical Trial
Official title:
Clinical Impact of Hypothermic Machine Perfusion in Renal Transplant Recipients
This is a multi-centers prospective, randomized, controlled trial. This trial will investigate the clinical outcome of kidney transplant recipients whose kidneys are under two different forms of organ preservation--hypothermic machine perfusion vs. static cold storage. Factors during the machine perfusion, such as the pressure, flow rate, and resistance index will also be investigated.
In this randomized clinical trial, 200 kidney pairs from deceased donors will be included in the study, which will be randomly assigned, one kidney to machine perfusion and the other to cold storage. All 400 patients will be followed for 1 year. The primary endpoint is delayed graft function (requiring dialysis in the first week after transplantation) and duration of delayed graft function. The second endpoints: GFR at week 1, month3, month6 and month 12 post-transplant. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT01663805 -
Effects of the Use of "de Novo" Everolimus in Renal Tranplant Population
|
Phase 4 | |
| Withdrawn |
NCT02658162 -
A Study on SANGUINATE™ for the Reduction of Delayed Graft Function in Kidney Transplant Patients
|
Phase 2 | |
| Recruiting |
NCT01513707 -
The Effects of Pre-transplant Dialysis Modality on Post-transplant Events
|
N/A | |
| Terminated |
NCT01403389 -
A Study of the Activity of Eculizumab for Prevention of Delayed Graft Function In Deceased Donor Kidney Transplant
|
Phase 2 | |
| Completed |
NCT02490202 -
Efficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Patients Receiving a Kidney Transplant
|
Phase 2/Phase 3 |